Trials / Completed
CompletedNCT00918268
Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2009/2010 Recommended in Northern Hemisphere in Non-elderly Adult and in Elderly Subjects
A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine, Formulation 2009-2010, When Administered to Non-elderly Adult and Elderly Subjects
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- Novartis Vaccines · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Annual trial for registration influenza vaccine with the strain composition for season 2009/2010.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Influenza vaccine | One 0.5mL dose of Inactivated, Influenza Vaccine using the strain composition 2009/2010 |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2009-06-11
- Last updated
- 2012-04-23
Locations
3 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT00918268. Inclusion in this directory is not an endorsement.